Company overview
Basic information
Company name
Medmonta, MB
Company code
307102053
Registered address
Kauno r. sav., Užliedžių sen., Giraitės k., Girios g. 2B-16, LT-54307
Registration date
2025-02-20
Company age: 1 y. 8 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Floor and wall covering
Ownership form
Private without foreign capital
MB Medmonta
Company code: 307102053
Address: Kauno r. sav., Užliedžių sen., Giraitės k., Girios g. 2B-16, LT-54307
Description
This description was generated by artificial intelligence.
Medmonta, MB (company code 307102053) is an operational private small partnership registered in 2025. The company belongs to the national private non-financial companies sector and is privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is CEO only. The company is classified as micro in size. Its activity is registered under EVRK code F.43.33.00, Floor and wall covering. The registered address is Girios g. 2B-16, Giraites k., Užliedžiu sen., Kauno r. sav., Kauno apskr., Lithuania.
For the 2025 financial year, covering 314 days, Medmonta reported revenue of EUR 27.2K and net profit of EUR 20.1K, with profit before tax also at EUR 20.1K. The profit margin was 73.9%. At year-end, equity stood at EUR 20.1K, liabilities at EUR 4.4K, and total assets at EUR 24.5K, all of which were current assets. Reported financial ratios included an ROE of 100.0%, ROA of 82.0%, an equity ratio of 82.0%, debt to equity of 0.22, and asset turnover of 1.11x. Staff metrics are referenced for so far in 2026.
For the 2025 financial year, covering 314 days, Medmonta reported revenue of EUR 27.2K and net profit of EUR 20.1K, with profit before tax also at EUR 20.1K. The profit margin was 73.9%. At year-end, equity stood at EUR 20.1K, liabilities at EUR 4.4K, and total assets at EUR 24.5K, all of which were current assets. Reported financial ratios included an ROE of 100.0%, ROA of 82.0%, an equity ratio of 82.0%, debt to equity of 0.22, and asset turnover of 1.11x. Staff metrics are referenced for so far in 2026.
Download a detailed company report
Make confident decisions with all the information about Medmonta, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.